PAVmed Inc. (PAVM)
PAVM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/0001437749-26-010115-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | PAVM on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001624326 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $71K |
| Net income | $401K |
| Operating income | -$21.8M |
| Net margin | 564.8% |
| Operating margin | -30712.7% |
| Revenue growth | -97.6% |
| Cash | $1.5M |
| Total assets | $38.8M |
| P/E (computed) | 34.9× |
| P/S (computed) | 197.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued." | 10-Q 2026-08-13 |
| Cash and burn | $3.8M cash; operating cash flow -$1.9M a quarter. | Report 2026-06-30 |
| Shares outstanding | 7,995,918 (2026-08-13); 21,932,914 a year earlier; 111,418,679 three years earlier. 1y figure adjusted for splits (1-for-30 overall); 3y figure adjusted for splits (1-for-450 overall). | Cover page 2026-08-13 |
| Reverse splits, 3 years | 2; latest 1-for-30 on 2026-01-02 | Source 2026-01-02 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2026-09-10 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-04-30 |
| Auditor | CBIZ CPAs P.C., New York, New York, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-04-25 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $33K | -$5.4M | -$2.7M | $3.8M | No debt tags | $112K | 10-Q 2026-08-13 |
| Q1 2026 2026-03-31 | $22K | -$60K | -$2.6M | $6.5M | No debt tags | $85K | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $52K | -$1.3M | -$1.6M | $1.5M | No debt tags | $71K | 10-K 2026-03-27 |
| Q3 2025 2025-09-30 | $5K | -$5.4M | -$896K | $3.1M | No debt tags | $19K | 10-Q 2025-11-12 |
| Q2 2025 2025-06-30 | $6K | -$11.9M | -$1.2M | $4.0M | No debt tags | $1.0M | 10-Q 2026-08-13 |
| Q1 2025 2025-03-31 | $8K | $19.0M | -$1.6M | $2.7M | No debt tags | $2.0M | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $0 | $1.4M | $94K | $1.2M | No debt tags | $3.0M | 10-K 2025-03-24 |
| Q3 2024 2024-09-30 | $1.0M | $64.4M | -$8.9M | $765K | No debt tags | $4.0M | 10-Q 2024-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-10 |
| Latest annual report FORM 10-K | 10-K | 2026-03-27 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-11-13 |
| Latest proxy | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 693 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +3.8% |
| 1 month | -38.3% |
| 3 months | -65.6% |
| Year to date | -75.4% |
| 1 year | -84.7% |
| From 52-week high | -86.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GUTS | Fractyl Health Inc. | $0.9918 | +9.76% | $13.2M |
| DRIO | DarioHealth Corp. | $1.15 | -8.73% | $13.0M |
| CTSO | Cytosorbents Corporation | $4.85 | -0.41% | $15.3M |
| SNWV | SANUWAVE Health Inc. | $1.81 | -0.55% | $15.6M |
| RVP | Retractable Technologies Inc. | $0.5600 | +0.02% | $16.8M |
| CVRX | CVRx Inc. | $0.6130 | +0.92% | $17.5M |
| FEMY | Femasys Inc. | $1.28 | -8.57% | $11.1M |
| PMI | Picard Medical Inc. | $7.24 | +0.14% | $17.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier